Skip to main content

Animations

MJFF Publications

3371 - 3380 of 6306 Results
Title
Year
  • Year
  • 2014
  • 2012
  • 2013
  • 2013
  • 2012
  • 2016
  • 2013
  • 2015
  • 2011
  • 2013
  • Summary Details
    OPEN
    Title: Noninvasive optical inhibition with a red-shifted microbial rhodopsin
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nn.3752
    Citation Count: 542
  • Summary Details
    OPEN
    Title: Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ncomms1669
    Citation Count: 243
  • Summary Details
    OPEN
    Title: Parkinson-related LRRK2 mutation R1441C/G/H impairs PKA phosphorylation of LRRK2 and disrupts its interaction with 14-3-3
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1312701111
    Citation Count: 119
  • Summary Details
    OPEN
    Title: Alpha-Synuclein Pathology and Axonal Degeneration of the Peripheral Motor Nerves Innervating Pharyngeal Muscles in Parkinson Disease
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/nen.0b013e3182801cde
    Citation Count: 142
  • Summary Details
    OPEN
    Title: Neuron‐to‐neuron transmission of α‐synuclein fibrils through axonal transport
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.23747
    Citation Count: 335
  • Summary Details
    OPEN
    Title: Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism
    Journal Name: Gene Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/gt.2016.62
    Citation Count: 78
  • Summary Details
    OPEN
    Title: Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(13)70210-2
    Citation Count: 261
  • Summary Details
    OPEN
    Title: Simple, Scalable Proteomic Imaging for High-Dimensional Profiling of Intact Systems
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.cell.2015.11.025
    Citation Count: 469
  • Summary Details
    OPEN
    Title: VPS35 Mutations in Parkinson Disease
    Journal Name: The American Journal of Human Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ajhg.2011.06.001
    Citation Count: 847
  • Summary Details
    OPEN
    Title: RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson’s Disease Risk
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.neuron.2012.11.033
    Citation Count: 511
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.